Skip to content
Lower risk Drug recall · FDA · Published January 5, 2017

InnovaGel Diphenhydramine HCl 25mg Capsules: Subpotent Risk

InnovaGel recalls 15,000-count bulk diphenhydramine capsules due to subpotent potency. This may cause ineffective treatment. Check product code MSU0048P or NDC 6897080284 for affected items.

🇺🇸 FDA recall #D-0674-2017DrugInnovaGel ›
Take action

Contact the company

Recalling firmInnovaGel14193 Sw 119th Ave · Miami, FL 33186-6013
✎ GovInfoNow plain-language explainer

What happened, in plain English

InnovaGel is recalling 15,000-count bulk diphenhydramine capsules because they may not contain enough active ingredient to be effective. This could lead to treatment failure for allergies or insomnia. Read more at govinfonow.com/recall/42094-innovagel-diphenhydramine-hcl-25mg-capsules-subpotent-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/42094-innovagel-diphenhydramine-hcl-25mg-capsules-subpotent-risk · Updated October 8, 2026 · FDA enforcement record: FDA #D-0674-2017

Cite this page

“InnovaGel Diphenhydramine HCl 25mg Capsules: Subpotent Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42094-innovagel-diphenhydramine-hcl-25mg-capsules-subpotent-risk. Based on FDA recall #D-0674-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0674-2017%22&limit=1).

Why it’s dangerous

The capsules have subpotent potency, meaning they contain less active medication than intended. This could result in the medication not working as expected for allergy or sleep symptoms.

Who’s affected

People who own or use the recalled diphenhydramine capsules for allergies or sleep issues. Those with higher doses or specific medical conditions may be at slightly higher risk.

How to tell if you have this one

Check for product code MSU0048P or NDC 6897080284 on the packaging. The capsules were sold in bulk drums with batch numbers 1404811 through 1603801, expiring December 2018.

  • Brand
    InnovaGel
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    NY only
Recall numberProduct, codes & lotsQuantity
D-0674-2017Diphenhydramine HCl 25 mg, Softgel Gelatin Capsule, 15,000-count bulk drums, aenova/Swiss Caps USA, Inc., 14193 S.W. 119th Avenue, Miami, FL 33186, Product Code MSU0048P, NDC 6897080284; Batch #: 1404811, 1409802, 1502817, 1504808, 1509810, 1511802, 1603801, Exp. 12/12/2018.Approximately 7,920,177 capsules
D-0675-2017Dye Free Allergy Softgel Gelatin Capsule, 15,000-count bulk drums, aenova/Swiss Caps USA, Inc., 14193 S.W. 119th Avenue, Miami, FL 33186, Product Code MSU0067P, NDC 6897080284; Batch #: 1508803,1602801, 1602802, 1604801, 1604802, 1606801, 1606802, 1606803, 1606804, Exp. 08/03/2018.9,992,768 softgels
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for product code MSU0048P or NDC 6897080284 on the packaging to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed in New York.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “NY only” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New York.

Recall timeline

FDA terminated this recall 4.7 years after the firm started it.

1. Firm started the recall: Jan 5, 201712. FDA classified it Class III: Apr 19, 201723. Published in FDA’s Enforcement Report: Apr 26, 201734. FDA terminated the recall: Sep 29, 2021420172021
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0674-2017 (January 5, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0674-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA